Home › Trial NCT00243594
Dendritic Cell Vaccination in Melanoma Patients Scheduled for Regional Lymph Node Dissection
- Trial IDNCT00243594
- StatusCompleted
- PhasePhase 1/2
- Study typeInterventional
- SponsorRadboud University Medical Center
- Enrollment40
- Start date1999-09
- ConditionsMelanoma Stage III or IV
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.